Induction of Egr-1 expression by the retinoid AHPN in human lung carcinoma cells is dependent on activated ERK1/2
- 1 April 2001
- journal article
- research article
- Published by Springer Nature in Cell Death & Differentiation
- Vol. 8 (4) , 411-424
- https://doi.org/10.1038/sj.cdd.4400818
Abstract
The novel retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (AHPN/CD437) inhibits cell proliferation and is a very effective inducer of apoptosis in a variety of carcinoma cell lines. In order to obtain greater insight into the mechanism of AHPN-induced growth arrest and apoptosis, we began to examine AHPN-induced changes in gene expression by cDNA array screening using human lung carcinoma H460 cells. This analysis identified several AHPN-inducible genes, including the immediate-early genes Egr-1 and Nur77. AHPN was able to increase Egr-1 and Nur77 mRNA expression and protein in a variety of carcinoma cell lines. This induction appeared to be regulated at the transcriptional level and was specific for AHPN since an RAR- and an RXR-selective retinoid were inactive. These results suggest that the induction of Egr-1 and Nur77 by AHPN is independent of nuclear retinoid receptors and involves a novel mechanism. Overexpression of Bcl-2, which inhibits AHPN-induced apoptosis but not growth arrest in human T cell lymphoma Molt-4 cells, did not block the induction of immediate-early gene expression. Treatment of H460 cells with AHPN induced activation of the p38 MAP-kinase but not the ERK1/2 signaling pathway. However, inhibition of the ERK1/2 signaling pathway by PD98059 blocked the induction of Egr-1 and Nur77 mRNA while the p38 MAPK inhibitor PD169316 had little effect. Expression of a dominant-negative ERK1 completely abolished the increase in Egr-1 mRNA. Treatment with MAPK inhibitors or expression of dnERK1 reduced but did not block AHPN-induced apoptosis. Our results suggest that the induction of Egr-1 in H460 by AHPN requires active ERK1/2 and is independent of p38 activation. Egr-1, in cooperation with several other growth-suppressor proteins, is likely involved in AHPN-induced inhibition of cell growth and cell death. Cell Death and Differentiation (2001) 8, 411–424Keywords
This publication has 60 references indexed in Scilit:
- Expression of Retinoid Receptor Genes and Proteins in Non-Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 1999
- Role of retinoid receptors in the regulation of mucin gene expression by retinoic acid in human tracheobronchial epithelial cellsBiochemical Journal, 1999
- Restoration of the Mucous Phenotype by Retinoic Acid in Retinoid-Deficient Human Bronchial Cell Cultures: Changes in Mucin Gene ExpressionAmerican Journal of Respiratory Cell and Molecular Biology, 1999
- Na+-K+-2Cl−cotransport in Ehrlich cells: regulation by protein phosphatases and kinasesAmerican Journal of Physiology-Cell Physiology, 1998
- One hundred years of journal publicationAmerican Journal of Physiology-Cell Physiology, 1998
- Retinoic acid treatment abrogates elastase-induced pulmonary emphysema in ratsNature Medicine, 1997
- Differential effects of all-trans and 13-cis-retinoic acid on mRNA levels of nuclear retinoic acid receptors in rat lung and liverBiochemical and Biophysical Research Communications, 1991
- Expression of nuclear retinoic acid receptors in normal tracheobronchial cells and in lung carcinoma cellsExperimental Cell Research, 1991
- Clinical trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasiaThe Journal of Pediatrics, 1987
- Synthesis of mucous glycoproteins by rabbit tracheal cells in vitro. Modulation by substratum, retinoids and cyclic AMPBiochemical Journal, 1987